Dallas, TX -- (SBWire) -- 11/26/2010 -- SandlerResearch announce Europe In Vitro Diagnostics Market Outlook to 2016

Europe In Vitro Diagnostics Market Outlook to 2016

GlobalData’s new report, “Europe In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Europe In Vitro Diagnostics market – UK, Germany, France, Italy, and Spain. The report provides value (USD million) data for all the market categories – Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture, and Haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Countries covered include UK, Germany, France, Italy, and Spain.

- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture, and Haematology.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2002 to 2009, forecast forward for 7 years to 2016.

- 2009 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Europe In Vitro Diagnostics market.

- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Biomerieux Sa, Beckman Coulter, Bio-Rad Laboratories, Ortho-Clinical Diagnostics, Becton, Dickinson and Company, Sysmex Corporation, Phadia, Qiagen, and Alere.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Europe In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize

1 Table of Contents 2

1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 15
2.1 What is This Report About? 15
3 Europe In Vitro Diagnostics 16
3.1 In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2002-2016 16
3.2 In Vitro Diagnostics, Europe, Overall Revenue ($m), 2002-2016 17
3.3 In Vitro Diagnostics, Europe, Company Share (2008-2009) 24
4 In Vitro Diagnostics In United Kingdom 26
4.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($m), 2002-2016 26
4.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2008-2009) 32
4.2.1 Clinical Chemistry, United Kingdom, Distribution Share (2008-2009) 32
4.2.2 Genetic Testing, United Kingdom, Distribution Share (2008-2009) 32
4.2.3 Haematology, United Kingdom, Distribution Share (2008-2009) 33
4.2.4 Histology and Cytology, United Kingdom, Distribution Share (2008-2009) 33
4.2.5 Immuno Chemistry, United Kingdom, Distribution Share (2008-2009) 34
4.2.6 Infectious Immunology, United Kingdom, Distribution Share (2008-2009) 34
4.2.7 Microbiology Culture, United Kingdom, Distribution Share (2008-2009) 35
4.3 In Vitro Diagnostics, United Kingdom, Company Share (2008-2009) 36
4.3.1 In Vitro Diagnostics, United Kingdom, Company Share (2008-2009) 36
4.3.2 Clinical Chemistry, United Kingdom, Company Share (2008-2009) 38
4.3.3 Genetic Testing, United Kingdom, Company Share (2008-2009) 40
4.3.4 Haematology, United Kingdom, Company Share (2008-2009) 42
4.3.5 Histology and Cytology, United Kingdom, Company Share (2008-2009) 44
4.3.6 Immuno Chemistry, United Kingdom, Company Share (2008-2009) 46
4.3.7 Infectious Immunology, United Kingdom, Company Share (2008-2009) 48
4.3.8 Microbiology Culture, United Kingdom, Company Share (2008-2009) 50
5 In Vitro Diagnostics In France 52
5.1 In Vitro Diagnostics, France, Overall Revenue ($m), 2002-2016 52
5.2 In Vitro Diagnostics, France, Distribution Share (2008-2009) 58
5.2.1 Clinical Chemistry, France, Distribution Share (2008-2009) 58
5.2.2 Genetic Testing, France, Distribution Share (2008-2009) 58
5.2.3 Haematology, France, Distribution Share (2008-2009) 59
5.2.4 Histology and Cytology, France, Distribution Share (2008-2009) 59
5.2.5 Immuno Chemistry, France, Distribution Share (2008-2009) 60
5.2.6 Infectious Immunology, France, Distribution Share (2008-2009) 60
5.2.7 Microbiology Culture, France, Distribution Share (2008-2009) 61
5.3 In Vitro Diagnostics, France, Company Share (2008-2009) 62
5.3.1 In Vitro Diagnostics, France, Company Share (2008-2009) 62
5.3.2 Clinical Chemistry, France, Company Share (2008-2009) 64
5.3.3 Genetic Testing, France, Company Share (2008-2009) 66
5.3.4 Haematology, France, Company Share (2008-2009) 68
5.3.5 Histology and Cytology, France, Company Share (2008-2009) 70
5.3.6 Immuno Chemistry, France, Company Share (2008-2009) 72
5.3.7 Infectious Immunology, France, Company Share (2008-2009) 74
5.3.8 Microbiology Culture, France, Company Share (2008-2009) 76
6 In Vitro Diagnostics In Germany 78
6.1 In Vitro Diagnostics, Germany, Overall Revenue ($m), 2002-2016 78
6.2 In Vitro Diagnostics, Germany, Distribution Share (2008-2009) 84
6.2.1 Clinical Chemistry, Germany, Distribution Share (2008-2009) 84
6.2.2 Genetic Testing, Germany, Distribution Share (2008-2009) 84
6.2.3 Haematology, Germany, Distribution Share (2008-2009) 85
6.2.4 Histology and Cytology, Germany, Distribution Share (2008-2009) 85
6.2.5 Immuno Chemistry, Germany, Distribution Share (2008-2009) 86
6.2.6 Infectious Immunology, Germany, Distribution Share (2008-2009) 86
6.2.7 Microbiology Culture, Germany, Distribution Share (2008-2009) 87
6.3 In Vitro Diagnostics, Germany, Company Share (2008-2009) 88
6.3.1 In Vitro Diagnostics, Germany, Company Share (2008-2009) 88
6.3.2 Clinical Chemistry, Germany, Company Share (2008-2009) 90
6.3.3 Genetic Testing, Germany, Company Share (2008-2009) 92
6.3.4 Haematology, Germany, Company Share (2008-2009) 94
6.3.5 Histology and Cytology, Germany, Company Share (2008-2009) 96
6.3.6 Immuno Chemistry, Germany, Company Share (2008-2009) 98
6.3.7 Infectious Immunology, Germany, Company Share (2008-2009) 100
6.3.8 Microbiology Culture, Germany, Company Share (2008-2009) 102
7 In Vitro Diagnostics In Italy 104
7.1 In Vitro Diagnostics, Italy, Overall Revenue ($m), 2002-2016 104
7.2 In Vitro Diagnostics, Italy Distribution Share (2008-2009) 110
7.2.1 Clinical Chemistry, Italy, Distribution Share (2008-2009) 110
7.2.2 Genetic Testing, Italy, Distribution Share (2008-2009) 110
7.2.3 Haematology, Italy, Distribution Share (2008-2009) 111
7.2.4 Histology and Cytology, Italy, Distribution Share (2008-2009) 111
7.2.5 Immuno Chemistry, Italy, Distribution Share (2008-2009) 112
7.2.6 Infectious Immunology, Italy, Distribution Share (2008-2009) 112
7.2.7 Microbiology Culture, Italy, Distribution Share (2008-2009) 113
7.3 In Vitro Diagnostics, Italy Company Share (2008-2009) 114
7.3.1 In Vitro Diagnostics, Italy, Company Share (2008-2009) 114
7.3.2 Clinical Chemistry, Italy, Company Share (2008-2009) 116
7.3.3 Genetic Testing, Italy, Company Share (2008-2009) 118
7.3.4 Haematology, Italy, Company Share (2008-2009) 120
7.3.5 Histology and Cytology, Italy, Company Share (2008-2009) 122
7.3.6 Immuno Chemistry, Italy, Company Share (2008-2009) 124
7.3.7 Infectious Immunology, Italy, Company Share (2008-2009) 126
7.3.8 Microbiology Culture, Italy, Company Share (2008-2009) 128
8 In Vitro Diagnostics In Spain 130
8.1 In Vitro Diagnostics, Spain, Overall Revenue ($m), 2002-2016 130
8.2 In Vitro Diagnostics, Spain, Distribution Share (2008-2009) 136
8.2.1 Clinical Chemistry, Spain, Distribution Share (2008-2009) 136
8.2.2 Genetic Testing, Spain, Distribution Share (2008-2009) 136
8.2.3 Haematology, Spain, Distribution Share (2008-2009) 137
8.2.4 Histology and Cytology, Spain, Distribution Share (2008-2009) 137
8.2.5 Immuno Chemistry, Spain, Distribution Share (2008-2009) 138
8.2.6 Infectious Immunology, Spain, Distribution Share (2008-2009) 138
8.2.7 Microbiology Culture, Spain, Distribution Share (2008-2009) 139
8.3 In Vitro Diagnostics, Spain Company Share (2008-2009) 140
8.3.1 In Vitro Diagnostics, Spain, Company Share (2008-2009) 140
8.3.2 Clinical Chemistry, Spain, Company Share (2008-2009) 142
8.3.3 Genetic Testing, Spain, Company Share (2008-2009) 144
8.3.4 Haematology, Spain, Company Share (2008-2009) 146
8.3.5 Histology and Cytology, Spain, Company Share (2008-2009) 148
8.3.6 Immuno Chemistry, Spain, Company Share (2008-2009) 150
8.3.7 Infectious Immunology, Spain, Company Share (2008-2009) 152
8.3.8 Microbiology Culture, Spain, Company Share (2008-2009) 154
9 Overview of Key Companies in Europe In Vitro Diagnostics Market 156
9.1 F. Hoffmann-La Roche Ltd. 156
9.1.1 Company Overview 156
9.1.2 Share in the Europe In Vitro Diagnostics Market 156
9.2 Siemens Healthcare 157
9.2.1 Company Overview 157
9.2.2 Share in the Europe In Vitro Diagnostics Market 157
9.3 Abbott Laboratories 158
9.3.1 Company Overview 158
9.3.2 Share in the Europe In Vitro Diagnostics Market 158
9.4 Beckman Coulter, Inc. 159
9.4.1 Company Overview 159
9.4.2 Share in the Europe In Vitro Diagnostics Market 159
9.5 bioMerieux S.A. 160
9.5.1 Company Overview 160
9.5.2 Share in the Europe In Vitro Diagnostics Market 160
9.6 Ortho-Clinical Diagnostics Inc. 161
9.6.1 Company Overview 161
9.6.2 Share in the Europe In Vitro Diagnostics Market 161
9.7 Bio-Rad Laboratories, Inc. 162
9.7.1 Company Overview 162
9.8 Becton, Dickinson and Company 162
9.8.1 Company Overview 162
9.9 Sysmex Corporation 163
9.9.1 Company Overview 163
9.10 Phadia AB 163
9.10.1 Company Overview 163
9.11 Alere Inc 163
9.11.1 Company Overview 163
9.12 Qiagen N.V. 164
9.12.1 Company Overview 164
9.13 Gen-Probe Incorporated 164
9.13.1 Company Overview 164
9.14 Hologic, Inc. 165
9.14.1 Company Overview 165
9.15 DiaSorin S.p.A 165
9.15.1 Company Overview 165
9.16 Mindray Medical International Limited 166
9.16.1 Company Overview 166
9.17 OLYMPUS CORPORATION 166
9.17.1 Company Overview 166
10 Financial Deals Landscape 167
10.1 Acquisition 167
10.1.1 3i Group to Sell Panreac Quimica to Illinois Tool Works 167
10.1.2 Thermo Fisher Scientific Completes Acquisition Of Finnzymes 168
10.1.3 Bio-AMD Holdings Receives Investment Of $1.28 Million From Flex Fuels Energy 169
10.1.4 Sonic Healthcare Completes Acquisition Of Medhold 170
10.1.5 MOCON Acquires Minority Equity Interest Of 16.9% In Luxcel Biosciences 171
10.1.6 QIAGEN Completes Acquisition Of ESE 172
10.1.7 Bio-Rad Laboratories Completes Acquisition Of Medical Diagnostics Segment From Biotest 173
10.1.8 Lab21 Acquires Delphic Diagnostic From BDO 175
10.2 Partnerships 176
10.2.1 BIOCRATES Life Sciences Enters Into Agreement With Chenomx 176
10.2.2 Diamedix Enters Into Distribution Agreement With Fumouze Diagnostics 177
10.2.3 Abbott Laboratories Enters Into An Agreement With GlaxoSmithKline 178
10.2.4 Polyplus-transfection Enters Into Licensing Agreement With metabion international 179
10.2.5 Transgenomic Enters Into Licensing Agreement With IntegraGen 180
10.2.6 ERYtech Pharma Enters Into An Agreement With The University of Texas M. D. Anderson Cancer Center 181
10.2.7 QIAGEN Enters Into Distribution Agreement With Celera 182
10.2.8 Sequenom Enters Into Licensing Agreement With Optherion 183
10.2.9 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 184
10.2.10 DiaGenic Enters Into Distribution Agreement With Ferrer inCode 185
10.2.11 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 186
10.2.12 Ferrer inCode Enters Into An Agreement With bioTheranostics 187
11 Recent Developments 188
11.1 Strategy and Business Planning 188
11.1.1 Oct 27, 2010: IntegraGen to Open US Subsidiary in Cambridge, Massachusetts 188
11.1.2 Sep 14, 2010: Oxford Nanopore Signs Collaboration With University Of Oxford 188
11.1.3 Sep 07, 2010: Octapharma Provides Update On New Heidelberg R&D Facility 188
11.1.4 Sep 02, 2010: Renishaw Opens New Facility 189
11.1.5 Aug 10, 2010: VirtualScopics Opens Second Office In Central Europe 190
11.1.6 Aug 09, 2010: NoAb BioDiscoveries And VigiCell Sign Collaboration And Co-Distribution Agreement In Principle 190
11.1.7 Jul 20, 2010: Covidien Opens European Services Center In Cherrywood Dublin 191
11.1.8 Jun 22, 2010: Ablynx Expands Into New R&D Facilities In Belgium 191
11.1.9 Jun 17, 2010: QIAGEN Expands Partnership With Genome Diagnostics For Development Of New Tests For Applications In Prevention And Personalized Healthcare 192
11.1.10 Jun 17, 2010: Baxter Opens New Research & Development Facility In Alliance Park, Belgium 193
11.1.11 Jun 15, 2010: SIRS-Lab, Analytik Jena Cooperate On Sepsis Diagnostics 193
11.1.12 Jun 11, 2010: Siemens Austria Opens New Headquarters In Vienna 193
11.1.13 May 27, 2010: NutriPharma ASA Changes Name To Bionor Pharma ASA 194
11.1.14 May 12, 2010: BIOCIUS Opens New Office In Switzerland 194
11.2 Legal and Regulatory 195
11.2.1 Sep 07, 2010: Precision BioSciences Wins Stay Of Patent Litigation Against Cellectis 195
11.2.2 Jul 08, 2010: Haemonetics Settles German Patent Suit With STRADIS-MED 195
11.2.3 May 13, 2010: Celsis IVT Settles LiverPool Patent Infringement Suit With XenoTech 195
11.3 Government and Public Interest 196
11.3.1 Oct 20, 2010: ESHRE Publishes New Guidelines For Preimplantation Genetic Diagnosis Screening 196
11.3.2 Oct 20, 2010: New Biological Sensor Detects And Analyses DNA Sequences: LIA 196
11.3.3 Oct 14, 2010: Urine Protein Could Pave Way For New Prostate Cancer Test: UK 197
11.3.4 Sep 30, 2010: Rostock Group Establishes Genomics Center In Moscow 197
11.3.5 Sep 15, 2010: New Rapid Test To Speed Up TB Diagnosis And Treatment: Health Protection Agency 198
11.3.6 Sep 14, 2010: Blood Test Accurately Predicts Death From Prostate Cancer Up To 25 Years In Advance: Memorial Sloan-Kettering Cancer Center 199
11.3.7 Sep 02, 2010: Gene Doping Detectable With Simple Blood Test: German Scientists 199
11.3.8 Sep 02, 2010: German Scientists From Tübingen And Mainz Develop Blood Test To Detect Gene Doping Even After 56 Days 200
11.3.9 Sep 01, 2010: European Collaborative Research To Develop Lab-On-Chip System For Cheap And Fast Cancer Diagnosis 201
11.3.10 Aug 16, 2010: UK Researchers Develop Diagnostic Test For Meningococcal Bacteria 202
11.3.11 Aug 09, 2010: New Dentist Test To Detect Oral Cancer Will Save Lives 203
11.3.12 Aug 04, 2010: New Guidelines For Direct-To-Consumer Genetic Tests: HGC 204
11.3.13 Jul 01, 2010: New Blood-Test To Aid In Schizophrenia Diagnosis: Cambridge University 205
11.3.14 Jun 30, 2010: Cell Test Could Predict DCIS Breast Cancer Recurrence: Cancer Research UK 205
11.3.15 Jun 28, 2010: Cheap, Simple, Noninvasive Blood Test May Replace Invasive Diagnostic Techniques In Early Pregnancy: Dutch Researchers 206
11.3.16 Jun 28, 2010: Danish Researchers Develop New Diagnostic Test For Bladder Cancer 207
11.3.17 Jun 28, 2010: Novo Nordisk US Headquarters Facility Receives LEED Silver Certification From USGBC 207
11.3.18 Jun 18, 2010: UK: Concateno Calls For Immediate Introduction Of Drug Driving Detection Devices 208
11.3.19 Jun 10, 2010: Chickenpox Study Could Lead To New Tests: University Of Edinburgh 209
11.4 Product News 209
11.4.1 Oct 27, 2010: PerkinElmer Releases DELFIA Xpress PlGF Assay In Europe For Early Detection Of Pre-eclampsia In Pregnant Women 209
11.4.2 Sep 20, 2010: Radiometer Adds Troponin T To AQT90 FLEX Immunoassay Analyzer 210
11.4.3 Sep 01, 2010: QIAGEN Launches QIAsymphony RGQ System For Molecular Diagnostics 210
11.4.4 Aug 31, 2010: Lab21 Launches Diagnostic Test For HIV 211
11.4.5 Aug 19, 2010: IMGM And Center For Human Genetics And Laboratory Medicine To Develop Workflows For Use Of 454 Sequencing Systems in Human Genetics 211
11.4.6 Aug 09, 2010: Sphere Medical Announces Positive Results From Clinical Study Of In Vitro Blood Gas Monitor 211
11.4.7 Jul 20, 2010: Roche Launches cobas e 602 Module For Immunoassay Testing 212
11.4.8 Jun 24, 2010: Progenika Grants Grifols World-Wide Distribution Rights For BLOODCHIP Genotyping Test For Blood Donors 212
11.4.9 May 28, 2010: Roche Diagnostics Receives FDA Approval For Elecsys Anti-HCV Assay 213
11.4.10 May 27, 2010: Applied BioCode Receives CE Mark Certification For BioCode-1000 Analyzer 213
11.4.11 May 27, 2010: Roche Launches Next-Generation GS Junior DNA Sequencing System 214
11.4.12 Apr 26, 2010: Osmetech Receives 510(k) Clearance For eSensor Thrombophilia Risk Test 214
11.4.13 Mar 31, 2010: AdvanDx Gets FDA 510(K) Approval For 90 Minutes PNA FISH Protocol 214
11.4.14 Jan 25, 2010: Haemonetics Announces Top Prize At UK Computing Awards For Its BloodTrack Transfusion Management System 215
11.4.15 Jan 25, 2010: Qiagen Introduces QIAsymphony AS 216
11.4.16 Jan 12, 2010: HairDX Forms Alliance For Distribution Of HairDX Genetic Test In Greece 216
11.4.17 Jan 11, 2010: Ipsogen And Institut Curie Forms Alliance For MapQuant Dx Grade Genomic HER2 And HR Tests 217
11.4.18 Jan 05, 2010: Axis-Shield And Bio-Rad Introduces BioPlex 2200 Anti-CCP Test For Early Detection Of Rheumatoid Arthritis 217
12 Appendix 218
12.1 Definitions of Markets Covered in the Report 219
12.1.1 In Vitro Diagnostics 219
12.2 Research Methodology 220
12.3 Secondary Research 220
12.4 Primary Research 221
12.5 Models 221
12.6 Forecasts 222
12.7 Expert Panels 222
12.8 GlobalData Consulting 222
12.9 Currency Conversion 223
12.10 Contact Us 223
12.11 Disclaimer 223

ABBREVIATIONS

Browse all : Medical Devices
http://www.sandlerresearch.org/market-research/medical-devices/

Browse all : GlobalData
http://www.sandlerresearch.org/publishers/globaldata/

Browse all : Newly Published
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports :

In Vitro Diagnostics Market - A Hotspot For Venture Capital Funding
http://www.sandlerresearch.org/reports/14586-in-vitro-diagnostics-market-a-hotspot-for-venture-capital-fundi.html
2010 U.S. In-Vitro Diagnostic Substance Manufacturing Industry Report
http://www.sandlerresearch.org/reports/18515-2010-us-in-vitro-diagnostic-substance-manufacturing-industry-re.html

The strategic challenges for remote diagnostics in Europe
http://www.sandlerresearch.org/reports/25599-the-strategic-challenges-for-remote-diagnostics-in-europe.html

Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
http://www.sandlerresearch.org/reports/25474-global-endoscopes-pipeline-analysis-opportunity-assessment-and-m.html

Global Hospital Information Systems (HIS) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
http://www.sandlerresearch.org/reports/25475-global-hospital-information-systems-his-opportunity-assessment.html

About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.

Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.

We also provide 24/7 online and offline support to our customers

Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/

Original Source : Vitro Diagnostics Market
http://www.sandlerresearch.org/reports/41252-europe-in-vitro-diagnostics-market-outlook-to-2016.html

Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html

Browse complete Report at : Europe In Vitro Diagnostics Market Outlook to 2016
http://www.sandlerresearch.org/reports/41252-europe-in-vitro-diagnostics-market-outlook-to-2016.html